Novavax, Inc. (NASDAQ: NVAX) In 2024: Reward Or Shame To Investors?

In the last trading session, 23.16 million shares of the Novavax, Inc. (NASDAQ:NVAX) were traded, and its beta was 1.98. Most recently the company’s share price was $14.00, and it changed around -$0.06 or -0.43% from the last close, which brings the market valuation of the company to $1.97B. NVAX currently trades at a discount to its 52-week high of $23.86, offering almost -70.43% off that amount. The share price’s 52-week low was $3.53, which indicates that the current value has risen by an impressive 74.79% since then. We note from Novavax, Inc.’s average daily trading volume that its 3-month average coming to 15.14 million.

Novavax, Inc. stock received a consensus recommendation rating of Hold, based on a mean score of 2.00. If we narrow it down even further, the data shows that 0 out of 7 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 5 recommended NVAX as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Novavax, Inc. (NASDAQ:NVAX) trade information

Instantly NVAX has showed a red trend with a performance of -0.43% at the end of last trading. The performance over the last five days has remained in the red territory. The company’s shares are currently up 191.67% year-to-date, but still down -6.98% over the last five days. On the other hand, Novavax, Inc. (NASDAQ:NVAX) is -6.10% down in the 30-day period.

The consensus price target as assigned by Wall Street analysts is $96.5, which translates to bulls needing to increase their stock price by 85.49% from its current value. Analyst projections state that NVAX is forecast to be at a low of $19 and a high of $174.

Novavax, Inc. (NVAX) estimates and forecasts

Novavax, Inc. share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 167.69 percent over the past six months and at a 109.06% annual growth rate that is well above the industry average of 15.20%.

Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 11.55%. Novavax, Inc. earnings are expected to increase by 107.92% in 2024, but the outlook is positive 37.90% per year for the next five years.